EAM Investors LLC bought a new position in shares of Envista Holdings Co. (NYSE:NVST – Get Rating) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 33,172 shares of the company's stock, valued at approximately $1,616,000.
Other large investors have also recently modified their holdings of the company. Vestmark Advisory Solutions Inc. raised its position in Envista by 4.9% during the 1st quarter. Vestmark Advisory Solutions Inc. now owns 5,514 shares of the company's stock valued at $269,000 after purchasing an additional 259 shares in the last quarter. Hotaling Investment Management LLC lifted its stake in Envista by 6.1% in the first quarter. Hotaling Investment Management LLC now owns 5,251 shares of the company's stock worth $256,000 after acquiring an additional 300 shares during the period. AE Wealth Management LLC grew its holdings in Envista by 5.1% during the 1st quarter. AE Wealth Management LLC now owns 6,672 shares of the company's stock worth $325,000 after acquiring an additional 324 shares in the last quarter. Virginia Retirement Systems ET AL increased its position in Envista by 1.1% during the 1st quarter. Virginia Retirement Systems ET AL now owns 37,000 shares of the company's stock valued at $1,802,000 after purchasing an additional 400 shares during the period. Finally, Crossmark Global Holdings Inc. raised its holdings in shares of Envista by 3.0% in the 1st quarter. Crossmark Global Holdings Inc. now owns 14,279 shares of the company's stock valued at $695,000 after purchasing an additional 410 shares in the last quarter.
Get
Envista alerts:
Analyst Upgrades and Downgrades
NVST has been the subject of several research reports. Piper Sandler raised shares of Envista from a "neutral" rating to an "overweight" rating and upped their price target for the stock from $40.00 to $46.00 in a research report on Monday, August 29th. Robert W. Baird cut Envista from an "outperform" rating to a "neutral" rating and dropped their target price for the company from $54.00 to $46.00 in a research report on Tuesday, June 14th. The Goldman Sachs Group decreased their price objective on Envista from $58.00 to $45.00 and set a "buy" rating for the company in a research note on Thursday, July 21st. Morgan Stanley dropped their price objective on Envista from $53.00 to $49.00 and set an "overweight" rating on the stock in a research report on Thursday, August 4th. Finally, Stifel Nicolaus reduced their target price on shares of Envista from $55.00 to $50.00 in a report on Friday, June 17th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $46.86.
Envista Price Performance
Shares of NYSE NVST opened at $35.43 on Wednesday. Envista Holdings Co. has a fifty-two week low of $34.75 and a fifty-two week high of $52.03. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.88 and a current ratio of 1.11. The company has a market cap of $5.79 billion, a PE ratio of 21.09, a P/E/G ratio of 1.42 and a beta of 1.54. The business has a 50-day simple moving average of $39.13 and a two-hundred day simple moving average of $42.62.
About Envista
(Get Rating)
Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands.
Recommended Stories
- Get a free copy of the StockNews.com research report on Envista (NVST)
- Bank Of America Sees Upside In These 2 European Alcohol Stocks
- 3 Low Beta Defensive Stocks for a Tough Market
- It Could Be a September to Remember for These 3 Stocks
- Peak Inflation Sets the Bottom for Brinker International Stock
- Can Roblox Reverse its Falling Bookings Amid Rising Engagements
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVST – Get Rating).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
